Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07321522 · ClinicalTrials.gov registry record · NA
Early Introduction and Sustained Ingestion (EISI) Using Two Educational Opportunities in Infants
A NA study, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT07321522: Recruiting NA study, sponsored by Stanford University.
NCT07321522 is a NA study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 92 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07321522, a NA study, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
The objective of the study is to see whether early feeding of potentially allergic foods can be increased with educational materials alone or with educational materials and additional in-person support opportunities. This study will help guide what types of support pediatricians and allergists give to new parents.
Primary Outcome
Compare the number of known allergenic foods introduced and sustained in the diet for 3 months in each study arm.
Interventions
- BEHAVIORAL Education and Opportunities on Early Introduction
- BEHAVIORAL Clinician Supervised Feeding of Known Allergenic Food
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2026-06-30 |
| Est. Completion | 2028-02 |
| Phase | NA |
What NCT07321522 shows while recruiting
NCT07321522 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Education and Opportunities on Early Introduction is the first listed.
NCT07321522 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07321522 about?
NCT07321522 is a clinical study titled "Early Introduction and Sustained Ingestion (EISI) Using Two Educational Opportunities in Infants". The objective of the study is to see whether early feeding of potentially allergic foods can be increased with educational materials alone or with educational materials and additional in-person support opportunities. This study will help guide what types of support pediatricians and allergists give ...
What is the current status of trial NCT07321522?
This trial is currently recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2026-06-30. Estimated completion is 2028-02.
What interventions are being tested in trial NCT07321522?
The interventions under investigation include: Education and Opportunities on Early Introduction (BEHAVIORAL), Clinician Supervised Feeding of Known Allergenic Food (BEHAVIORAL).
Who is sponsoring clinical trial NCT07321522?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07321522's enrollment target sits among peer trials
92 937th of 2000 higher than 1,062 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI